• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Biological Sciences
  2. Vol 15 (2), 2015
  3. 102-105
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Biological Sciences

Year: 2015 | Volume: 15 | Issue: 2 | Page No.: 102-105
DOI: 10.3923/jbs.2015.102.105

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 77

Authors


Socorrina Colaco

Country: India

N. Ramesh

Country: India

Sekar Rajan

Country: India

Subramania Nainar Meyyanathan

Country: India

Keywords


  • Dextromethorphan hydrobromide sustained release tablet and immediate release tablets
  • HPLC
  • pharmacokinetic study
Research Article

A Single-Dose, Three-Period, Six-Sequence Crossover Study Comparing the Bioavailability Study of Dextromethorphan Hydrobromide Sustained Release (SR) Tablet and the Immediate Release (IR) Tablet in Healthy Volunteers Under Fasting Condition

Socorrina Colaco, N. Ramesh, Sekar Rajan and Subramania Nainar Meyyanathan
Objective was to compare pharmacokinetic characteristics of Sustained-Release (SR) and Immediate-Release (IR) formulations of dextromethorphan hydrobromide following a single oral administration of test and reference formulations in fasting healthy male volunteers. A randomized, 3-way, crossover, bioequivalence study was conducted in 6 healthy male volunteers to compare dextromethorphan hydrobromide Sustained Release (SR) tablet as test and the Immediate Release (IR) as reference product. Blood samples were collected and plasma samples were determined by using validated HPLC method involving a solid phase extraction method. Pharmacokinetic parameters were calculated by non-compartmental analysis. Cmax of the sustained-release formulation was significantly lower than that of the marketed immediate-release. The Tmax of sustained-release formulation was significantly long-lasting than that of immediate release. These results are in line with the profile of a sustained-release drug. This was also evident by the lower elimination rate and higher t½ values. However, the bioavailability of sustained-release tablets remained the identical as that of immediate release tablets.
PDF Fulltext XML References Citation

How to cite this article

Socorrina Colaco, N. Ramesh, Sekar Rajan and Subramania Nainar Meyyanathan, 2015. A Single-Dose, Three-Period, Six-Sequence Crossover Study Comparing the Bioavailability Study of Dextromethorphan Hydrobromide Sustained Release (SR) Tablet and the Immediate Release (IR) Tablet in Healthy Volunteers Under Fasting Condition. Journal of Biological Sciences, 15: 102-105.

DOI: 10.3923/jbs.2015.102.105

URL: https://scialert.net/abstract/?doi=jbs.2015.102.105

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved